Head-to-head · WeighScore
Fresh Day Meds vs Gimme Care
By GLP-1 ScorecardUpdated
Score comparison
Gimme Care has the higher recorded score — 84.6/100 to 84.3/100, but only just.
Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bundled compounded injections with lower advertised rates on longer plans; confirm the initial charge and renewal dates. Fresh Day Meds is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Fresh Day Meds review and the Gimme Care review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Fresh Day Meds vs Green Cap Health and Gimme Care vs Green Cap Health compare each of them with another graded program, and the list of alternatives to Fresh Day Meds ranks the programs closest to Fresh Day Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the RxSpan MD review covers one graded close to these two, at 84.3/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Fresh Day Meds | Gimme Care |
|---|---|---|
| WeighScore | 84.3/100 | 84.6/100 |
| Grade | B | B |
| Site position | #18 | #15 |
| Semaglutide | $237 three-month plan or $120 one-month, new or transfer (White Label or Drug Crafters fulfillment); renews every 23 or 83 days, confirm selected total | $160 one-month plan; $130/month on three-month plan or $119/month on six-month plan; confirm initial charge and renewal dates |
| Tirzepatide | $267 three-month plan or $125 one-month (Black Friday offer to Dec 1; White Label or Drug Crafters fulfillment); renews every 23 or 83 days, confirm selected total | $199 one-month plan; $163/month on three-month plan or $149/month on six-month plan; confirm initial charge and renewal dates |
| Coverage | Advertises 49 states plus DC; Arkansas excluded for compounded GLP-1s | Advertises all 50 states plus DC; state-specific initial audio/video requirements apply |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Same published total for new and transfer patients
- Care and supplies advertised included
- Confirmed pause can stop future refills
What to consider
- Billing is not calendar-monthly
- Approved orders and future refills have different cancellation rules
- Arkansas GLP-1 access excluded
- Assigned clinician and pharmacy need confirmation
Strengths
- Portal pause or cancellation
- Pre-dispense order cancellation
- Unavailable-treatment refund exception
What to consider
- Assigned pharmacy not established
- Support-change notice required
- Refund eligibility is conditional
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.